Ayer MLX-Centered Transcription Networks Coordination of Nutrient Availability and Utilization by MAX-and Subject Collection MYC and the Pathway to Cancer MYC Degradation

[1]  Jianbiao Zhou,et al.  Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. , 2013, Mitochondrion.

[2]  A. Shaywitz,et al.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. , 2013, Molecular cell.

[3]  Z. Al-Oanzi,et al.  Glucose Induces Protein Targeting to Glycogen in Hepatocytes by Fructose 2,6-Bisphosphate-Mediated Recruitment of MondoA to the Promoter , 2012, Molecular and Cellular Biology.

[4]  Jared L. Johnson,et al.  Interactions between epigenetics and metabolism in cancers , 2012, Front. Oncol..

[5]  J. Maris,et al.  ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. , 2012, Cancer cell.

[6]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[7]  D. Green,et al.  c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells , 2012, Cell.

[8]  D. Green,et al.  Metabolic checkpoints in activated T cells , 2012, Nature Immunology.

[9]  S. Burdach,et al.  MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival. , 2012, Leukemia research.

[10]  F. Urano,et al.  Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. , 2012, Cell metabolism.

[11]  V. Hietakangas,et al.  Glucose sensing by ChREBP/MondoA-Mlx transcription factors. , 2012, Seminars in cell & developmental biology.

[12]  P. Greengard,et al.  IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. , 2012, Cell metabolism.

[13]  Chi V Dang,et al.  Links between metabolism and cancer. , 2012, Genes & development.

[14]  Richard T. Lee,et al.  An expanded family of arrestins regulate metabolism , 2012, Trends in Endocrinology & Metabolism.

[15]  W. Atchley,et al.  A Novel N-Terminal Domain May Dictate the Glucose Response of Mondo Proteins , 2012, PloS one.

[16]  Marc E. Lenburg,et al.  MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition , 2012, The Journal of experimental medicine.

[17]  Z. Al-Oanzi,et al.  Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. , 2012, The Biochemical journal.

[18]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[19]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[20]  R. Deberardinis,et al.  Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? , 2012, Cell.

[21]  Takashi Tsukamoto,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[22]  Qiang Yu,et al.  TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms. , 2011, The international journal of biochemistry & cell biology.

[23]  P. Sandy,et al.  Targeting MYC dependence in cancer by inhibiting BET bromodomains , 2011, Proceedings of the National Academy of Sciences.

[24]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[25]  T. Choe,et al.  TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1 , 2011, Oncogene.

[26]  W. Atchley,et al.  Evolution of the Max and Mlx Networks in Animals , 2011, Genome biology and evolution.

[27]  Chris Sander,et al.  18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. , 2011, Cancer research.

[28]  J. Chi,et al.  Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia , 2011, PLoS genetics.

[29]  D. Ayer,et al.  An extended Myc network contributes to glucose homeostasis in cancer and diabetes. , 2011, Frontiers in bioscience.

[30]  R. Deberardinis,et al.  Glutamine: pleiotropic roles in tumor growth and stress resistance , 2011, Journal of Molecular Medicine.

[31]  J. Martin-Serrano,et al.  Multiple Interactions between the ESCRT Machinery and Arrestin-Related Proteins: Implications for PPXY-Dependent Budding , 2010, Journal of Virology.

[32]  Stephanie Roessler,et al.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. , 2010, Cancer research.

[33]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[34]  D. Ayer,et al.  Transcriptional and Translational Downregulation of Thioredoxin Interacting Protein Is Required for Metabolic Reprogramming during G(1). , 2010, Genes & cancer.

[35]  Daniel Merl,et al.  Lactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA , 2010, PLoS genetics.

[36]  D. Ayer,et al.  Coordination of glucose and glutamine utilization by an expanded Myc network , 2010, Transcription.

[37]  Derek Y. Chiang,et al.  Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy , 2010, Nature Genetics.

[38]  K. Ickstadt,et al.  Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer , 2010, Breast Cancer Research.

[39]  H. Masutani,et al.  Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells. , 2010, Immunology letters.

[40]  D. Ayer,et al.  Myc, mondo, and metabolism. , 2010, Genes & cancer.

[41]  S. Shurtleff,et al.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  P. Saha,et al.  Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). , 2010, Biochemical and biophysical research communications.

[43]  R. Deberardinis,et al.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.

[44]  Kate Schroder,et al.  The NLRP3 Inflammasome: A Sensor for Metabolic Danger? , 2010, Science.

[45]  C. Dang,et al.  MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities , 2009, Clinical Cancer Research.

[46]  D. Ayer,et al.  Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity , 2009, Proceedings of the National Academy of Sciences.

[47]  Sarah A. Pendergrass,et al.  A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response , 2009, PloS one.

[48]  Richard T. Lee,et al.  Thioredoxin-independent Regulation of Metabolism by the α-Arrestin Proteins* , 2009, The Journal of Biological Chemistry.

[49]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[50]  Debra L Winkeljohn.  Triple-negative breast cancer. , 2008, Clinical journal of oncology nursing.

[51]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[52]  M. West,et al.  The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers , 2008, PLoS genetics.

[53]  R. Eisenman,et al.  Myc's broad reach. , 2008, Genes & development.

[54]  Laurent Ozbun,et al.  A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. , 2008, Cancer research.

[55]  D. Ayer,et al.  Glucose sensing by MondoA:Mlx complexes: A role for hexokinases and direct regulation of thioredoxin-interacting protein expression , 2008, Proceedings of the National Academy of Sciences.

[56]  Y. S. Kim,et al.  VDUP1 mediates nuclear export of HIF1α via CRM1-dependent pathway , 2008 .

[57]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[58]  Roger A. Davis,et al.  Txnip balances metabolic and growth signaling via PTEN disulfide reduction , 2008, Proceedings of the National Academy of Sciences.

[59]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[60]  Robyn L Prueitt,et al.  Tumor immunobiological differences in prostate cancer between African-American and European-American men. , 2008, Cancer research.

[61]  J. Chung,et al.  Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. , 2007, Cellular & molecular immunology.

[62]  N. Curthoys,et al.  Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES). , 2007, The Biochemical journal.

[63]  C. Thompson,et al.  HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. , 2007, Cancer cell.

[64]  J. Girard,et al.  ChREBP, a transcriptional regulator of glucose and lipid metabolism. , 2007, Annual review of nutrition.

[65]  Nicola Zamboni,et al.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.

[66]  D. Muoio.  TXNIP links redox circuitry to glucose control. , 2007, Cell metabolism.

[67]  R. Spang,et al.  Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia , 2007, Leukemia.

[68]  Allan Vaag,et al.  TXNIP Regulates Peripheral Glucose Metabolism in Humans , 2007, PLoS medicine.

[69]  H. Towle,et al.  ChREBP•Mlx Is the Principal Mediator of Glucose-induced Gene Expression in the Liver* , 2006, Journal of Biological Chemistry.

[70]  J. Repa,et al.  Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.

[71]  D. Ayer,et al.  MondoA-Mlx Heterodimers Are Candidate Sensors of Cellular Energy Status: Mitochondrial Localization and Direct Regulation of Glycolysis , 2006, Molecular and Cellular Biology.

[72]  H. Aburatani,et al.  Hepatocellular carcinoma in Txnip-deficient mice , 2006, Oncogene.

[73]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[74]  David E. Misek,et al.  Delineation, Functional Validation, and Bioinformatic Evaluation of Gene Expression in Thyroid Follicular Carcinomas with the PAX8-PPARG Translocation , 2006, Clinical Cancer Research.

[75]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[76]  C. Distelhorst,et al.  Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis , 2006, Oncogene.

[77]  Carlos Cordon-Cardo,et al.  Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  Yixin Wang,et al.  Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions , 2005, Clinical Cancer Research.

[79]  Marie Joseph,et al.  Gene Signatures of Progression and Metastasis in Renal Cell Cancer , 2005, Clinical Cancer Research.

[80]  N. Segal,et al.  Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. , 2005, Cancer research.

[81]  Chae Young Hwang,et al.  Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. , 2005, Cancer research.

[82]  N. Socci,et al.  Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. , 2005, Cancer research.

[83]  Adam A. Margolin,et al.  Reverse engineering of regulatory networks in human B cells , 2005, Nature Genetics.

[84]  R. Abseher,et al.  Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[85]  Bruce J. Aronow,et al.  Chromatin Immunoprecipitation Assays Footprints in Glycolytic Genes by Evaluation of Myc E-box Phylogenetic Supplemental Material , 2004 .

[86]  Todd R Golub,et al.  Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation , 2004, Nature Genetics.

[87]  D. Ayer,et al.  A Novel Heterodimerization Domain, CRM1, and 14-3-3 Control Subcellular Localization of the MondoA-Mlx Heterocomplex , 2002, Molecular and Cellular Biology.

[88]  D. Botstein,et al.  Diversity of gene expression in adenocarcinoma of the lung , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[89]  D. Ayer,et al.  MondoA, a Novel Basic Helix-Loop-Helix–Leucine Zipper Transcriptional Activator That Constitutes a Positive Branch of a Max-Like Network , 2000, Molecular and Cellular Biology.

[90]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[91]  A. Pardee,et al.  A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[92]  J. Girard,et al.  Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. , 2012, Journal of hepatology.

[93]  Tsung-Cheng Chang,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2009, Nature.

[94]  John T. Wei,et al.  Integrative molecular concept modeling of prostate cancer progression , 2007, Nature Genetics.

[95]  D. Ayer,et al.  The Mlx network: evidence for a parallel Max-like transcriptional network that regulates energy metabolism. , 2006, Current topics in microbiology and immunology.

[96]  E. Lander,et al.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. , 2001, Proceedings of the National Academy of Sciences of the United States of America.